An antigenic variation is the mechanism by which an infectious organism changes its surface proteins in favour of circumventing a host immune response.
Antigenic variation is a mechanism used by certain pathogens, such as viruses and bacteria, to change their surface antigens, making it difficult for the immune system to recognize and mount an effective response against them. This allows the pathogen to evade immune detection and establish persistent infections in the host.
The Phase Variation is the reversible ability of some bacteria to turn an and off the expression of genes coding for the surface antigens . While the Antigenic Variation is the modification of the gene for an expressed surface antigen by genetic recombination with one of many variable unexpressed DNA sequences. In this manner , the expressed surface antigen can assume many different antigenic structures
The suffix of antigenic is -ic.
Words " Antigenic Determinant " itself yells that it is on antigen
RNA genome of influenza virus is segmented in to 7 pieces. It has the unique property of undergoing two types of genetic variation ie antigenic drift and antigenic shift. In antigenic drift the antigenic variations are minor where genetic recombination take place between strains of two similar species whereas in antigenic shift the recombination take place between strains of dissimilar species leading to major antigenic variations and hence seasonal epidemics.
antigenic when bound to proteins
Antigens with only one antigenic site are called Major histocompatibility complex (MHC)
Swine flu H1N1 is considered an antigenic shift, as it resulted from a reassortment of genetic material from different influenza virus strains in animals. This led to the emergence of a new subtype that can infect humans.
the technical is a antigenic, frogulation.
influenza A viruses can trade genetic materials with the viruses of other species. Two different strains trade or merge material, a process known as an antigenic shift.
Yes, monoclonal antibodies can be specific for multiple antigenic determinants if those determinants share similar structural features that allow the antibody to bind to them. This property is known as cross-reactivity. However, some monoclonal antibodies are designed to target a single specific antigenic determinant to ensure high specificity in diagnostic or therapeutic applications.
a segmented genome